• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“临界”超声再评估在 Bethesda III 甲状腺结节决策中的作用。

The Role of "Critical" Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules.

机构信息

Unit of General and Emergency Surgery, Department of Surgical Oncological and Oral Sciences, Policlinico "P. Giaccone", University of Palermo, Via Liborio Giuffré 5, 90127 Palermo, Italy.

Unit of Oncological Surgery, Department of Surgical Oncology and Oral Sciences, University of Palermo, Via L. Giuffré, 5, 90127 Palermo, Italy.

出版信息

Medicina (Kaunas). 2023 Aug 17;59(8):1484. doi: 10.3390/medicina59081484.

DOI:10.3390/medicina59081484
PMID:37629774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10456377/
Abstract

: Bethesda III (BIII) thyroid nodules have an expected malignancy rate of 5-15%. Our purpose was to assess which US criteria are most associated with cancer risk, and the value of critical ultrasound (US) reassessment. : From 2018 to 2022, 298 BIII nodules were enrolled for thyroidectomy (79 malignancies). We evaluated ultrasonographic data: hechogenicity, intralesional vascularization, spiculated margins, micro-calcifications, "taller than wide" shape, extra-thyroidal growth, size increase, as well as their association with histology. We also evaluated if the ultrasound reassessment modified the strategy. : Spiculated margins and microcalcification were significantly correlated with malignancy risk. Spiculated margins showed a specificity of 0.95 IC95% (0.93-0.98); sensitivity 0.70 IC95% (0.59-0.80). Microcalcifications showed a sensitivity of 0.87 CI95% (0.80-0.94); specificity 0.75 CI95% (0.72-0.83). The presence of these signs readdressed the strategy in 76/79 cases Then, the indication for surgery was appropriate in 75% of cases. : Microcalcifications and spiculated margins should be routinely sought during a final ultrasound reassessment in BIII nodules. These signs allowed for a modification of the strategy in favor of surgery in 96% of the cases that were not otherwise referred to surgery. The importance of integrating ultrasound and cytology in the evaluation of BIII thyroid nodules is confirmed. Reassessment with ultrasound of BIII nodules allowed for a redirection of the surgical choice.

摘要

贝塞斯达分类法 3 级(BIII)甲状腺结节的恶性肿瘤发生率为 5-15%。我们的目的是评估哪些超声标准与癌症风险最相关,以及关键超声(US)重新评估的价值。

从 2018 年到 2022 年,共有 298 个 BIII 结节被纳入甲状腺切除术(79 例恶性肿瘤)。我们评估了超声数据:回声性质、瘤内血管化、刺状边缘、微钙化、“高宽比”形状、甲状腺外生长、大小增加,以及它们与组织学的关系。我们还评估了超声重新评估是否改变了治疗策略。

刺状边缘和微钙化与恶性肿瘤风险显著相关。刺状边缘的特异性为 0.95 IC95%(0.93-0.98);敏感性为 0.70 IC95%(0.59-0.80)。微钙化的敏感性为 0.87 CI95%(0.80-0.94);特异性为 0.75 CI95%(0.72-0.83)。这些征象的存在在 76/79 例病例中重新调整了治疗策略。然后,在 75%的病例中,手术指征是合适的。

微钙化和刺状边缘应在 BIII 结节的最终超声重新评估中常规寻找。这些征象使得在 96%的未进行手术的病例中,修改了手术策略。证实了在 BIII 甲状腺结节评估中整合超声和细胞学的重要性。BIII 结节的超声重新评估允许重新定向手术选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/3c8ce800daae/medicina-59-01484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/a3b6f2f7d879/medicina-59-01484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/899c67e968ad/medicina-59-01484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/407053baad89/medicina-59-01484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/3c8ce800daae/medicina-59-01484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/a3b6f2f7d879/medicina-59-01484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/899c67e968ad/medicina-59-01484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/407053baad89/medicina-59-01484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05c/10456377/3c8ce800daae/medicina-59-01484-g004.jpg

相似文献

1
The Role of "Critical" Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules.“临界”超声再评估在 Bethesda III 甲状腺结节决策中的作用。
Medicina (Kaunas). 2023 Aug 17;59(8):1484. doi: 10.3390/medicina59081484.
2
Bethesda III thyroid nodules: the role of ultrasound in clinical decision making.贝塞斯达Ⅲ类甲状腺结节:超声在临床决策中的作用
Ann Surg Oncol. 2014 Oct;21(11):3528-33. doi: 10.1245/s10434-014-3749-8. Epub 2014 May 8.
3
Ultrasonographic predictors of thyroid cancer in Bethesda III and IV thyroid nodules.在 Bethesda III 和 IV 甲状腺结节中甲状腺癌的超声预测因素。
Front Endocrinol (Lausanne). 2024 Feb 9;15:1326134. doi: 10.3389/fendo.2024.1326134. eCollection 2024.
4
Impact of Microcalcifications on Risk of Malignancy in Thyroid Nodules with Indeterminate or Benign Cytology.微小钙化对甲状腺结节细胞学检查结果为不确定或良性时恶性风险的影响。
Otolaryngol Head Neck Surg. 2016 Jan;154(1):46-51. doi: 10.1177/0194599815605326. Epub 2015 Sep 21.
5
The role of thyroid sonographic malignancy risk features when the fine needle aspiration biopsy result is indeterminate.当细针穿刺活检结果不确定时,甲状腺超声恶性风险特征的作用。
Endokrynol Pol. 2022;73(2):316-324. doi: 10.5603/EP.a2022.0027.
6
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
7
Clinical value of using ultrasound to assess calcification patterns in thyroid nodules.超声评估甲状腺结节内钙化模式的临床价值。
World J Surg. 2011 Jan;35(1):122-7. doi: 10.1007/s00268-010-0827-3.
8
Ultrasound criteria (EU-TIRADS) to identify thyroid nodule malignancy risk in adolescents. Correlation with cyto-histological findings.青少年甲状腺结节良恶性风险的超声标准(EU-TIRADS)。与细胞组织学发现的相关性。
Endocrinol Diabetes Nutr (Engl Ed). 2021 Dec;68(10):728-734. doi: 10.1016/j.endien.2020.11.006. Epub 2021 Dec 8.
9
An attempt to reduce unnecessary surgical procedures... Can ultrasound characteristics help in differentiating adenoma vs carcinoma in follicular thyroid neoplasms?尝试减少不必要的手术操作……超声特征能否有助于区分滤泡性甲状腺肿瘤中的腺瘤与癌?
Radiologia (Engl Ed). 2023 Jan-Feb;65(1):22-31. doi: 10.1016/j.rxeng.2020.09.007. Epub 2022 Jun 2.
10
Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies.甲状腺超声特征与癌风险:观察性研究的系统评价和荟萃分析
Thyroid. 2015 May;25(5):538-50. doi: 10.1089/thy.2014.0353. Epub 2015 Mar 31.

引用本文的文献

1
A narrative review on innovations of thyroid nodule ultrasound diagnosis: applications of robot and artificial intelligence technology.甲状腺结节超声诊断创新的叙述性综述:机器人与人工智能技术的应用
Gland Surg. 2025 Jul 31;14(7):1379-1389. doi: 10.21037/gs-2025-75. Epub 2025 Jul 28.

本文引用的文献

1
Molecular testing in fine-needle aspiration of thyroid nodules.甲状腺结节细针穿刺活检中的分子检测
Diagn Cytopathol. 2023 Jan;51(1):36-50. doi: 10.1002/dc.25035. Epub 2022 Aug 11.
2
How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules?分子检测在术前决策中对甲状腺结节处理的不确定性的应用效果如何?
World J Surg. 2022 Dec;46(12):3043-3050. doi: 10.1007/s00268-022-06744-1. Epub 2022 Sep 27.
3
Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS.
使用重复细针穿刺活检(FNA)和甲状腺影像报告和数据系统(TIRADS)优化Ⅲ类甲状腺结节的管理
Cancers (Basel). 2022 Sep 16;14(18):4489. doi: 10.3390/cancers14184489.
4
Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III.甲状腺结节 Bethesda 分类为 III 类的恶性肿瘤预测因素。
Front Endocrinol (Lausanne). 2022 Feb 16;13:806028. doi: 10.3389/fendo.2022.806028. eCollection 2022.
5
The Prediction of Malignancy Risk in Thyroid Nodules Classified as Bethesda System Category III (AUS/FLUS) and the Role of Ultrasound Finding for Prediction of Malignancy Risk.甲状腺结节分类为贝塞斯达系统III类(AUS/FLUS)时恶性风险的预测以及超声检查结果在预测恶性风险中的作用。
Cureus. 2021 Sep 13;13(9):e17924. doi: 10.7759/cureus.17924. eCollection 2021 Sep.
6
Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients.基于手术患者中慢性淋巴细胞性甲状腺炎的存在,贝塞斯达分类法 III 级甲状腺结节的恶性率。
Front Endocrinol (Lausanne). 2021 Sep 30;12:745395. doi: 10.3389/fendo.2021.745395. eCollection 2021.
7
Approach to Bethesda system category III thyroid nodules according to US-risk stratification.根据美国风险分层,贝塞斯达系统类别 III 甲状腺结节的处理方法。
Endocr J. 2022 Jan 28;69(1):67-74. doi: 10.1507/endocrj.EJ21-0300. Epub 2021 Aug 18.
8
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer.RAS突变在甲状腺良性结节和非髓样甲状腺癌中的意义
Cancers (Basel). 2021 Jul 27;13(15):3785. doi: 10.3390/cancers13153785.
9
Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China.贝塞斯达分类法第 III 类(AUS/FLUS)的再分类:基于中国国家癌症中心 ThinPrep 切片的甲状腺细针抽吸细胞学研究。
Cancer Cytopathol. 2021 Aug;129(8):642-648. doi: 10.1002/cncy.22417. Epub 2021 Jun 17.
10
Outcome of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid fine-needle aspirations: A six-year institutional experience.甲状腺细针抽吸标本中意义不明的非典型性/滤泡性病变的结局:六年机构经验。
Diagn Cytopathol. 2021 Aug;49(8):915-920. doi: 10.1002/dc.24771. Epub 2021 May 11.